Elevated melatonin levels in natalizumab-treated female patients with relapsing-remitting multiple sclerosis: Relationship to oxidative stress. Bahamonde C, Conde C, Agüera E, Lillo R, Luque E, Gascón F, Feijóo M, Cruz AH, Sánchez-López F, Túnez I Eur J Pharmacol. 2014 Feb 25; 730C:26-30. PMID: 24582759. Abstract CommentRecommendBookmarkWatch